X0508 4 2024-08-12 0001601485 Elicio Therapeutics, Inc. ELTX 0001979324 Chudnovsky Yekaterina C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR BOSTON MA 02210 true true 0001977769 GKCC, LLC 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 true false Convertible Note (convertible into Common Stock) 5.81 2024-08-12 4 P 0 3442341 5.81 A Common Stock 3442341 3442341 I Held by GKCC, LLC On August 12, 2024, GKCC, LLC (the "Purchaser") purchased from the Issuer a convertible note with an aggregate principal amount of $20,000,000 (the "Convertible Note"). The Convertible Note is convertible into shares of common stock of the Issuer at a conversion price of $5.81 per share, subject to adjustment in certain circumstances. Therefore, the Convertible Note is initially convertible into approximately 3,442,341 shares of common stock of the Issuer. The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum. Yekaterina (Katie) Chudnovsky is the sole member and manager of the Purchaser and may be deemed to beneficially own the shares held by the Purchaser. /s/ Yekaterina Chudnovsky 2024-08-14 /s/ Yekaterina Chudnovsky, Manager GKCC, LLC 2024-08-14